Wikidata

(Q55073162)

English

Phase 2, multicenter, single-arm study of eribulin mesylate with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
Phase 2, multicenter, single-arm study of eribulin mesylate with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25024001
retrieved
17 June 2018
reference URL
http://europepmc.org/abstract/MED/25024001

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q55073162&oldid=1651652838"